SUPPLEMENTAL INDENTURESupplemental Indenture • January 24th, 2014 • Viropharma Inc • Pharmaceutical preparations • New York
This Supplemental Indenture (this “Supplemental Indenture”) is dated as of January 24, 2014 between ViroPharma Incorporated, a Delaware corporation (the “Issuer”), and Wilmington Trust Company, a Delaware trust company, as Trustee under the Indenture defined below (the “Trustee”).
